Literature DB >> 23959878

Human α-L-iduronidase uses its own N-glycan as a substrate-binding and catalytic module.

Nobuo Maita1, Takahiro Tsukimura, Takako Taniguchi, Seiji Saito, Kazuki Ohno, Hisaaki Taniguchi, Hitoshi Sakuraba.   

Abstract

N-glycosylation is a major posttranslational modification that endows proteins with various functions. It is established that N-glycans are essential for the correct folding and stability of some enzymes; however, the actual effects of N-glycans on their activities are poorly understood. Here, we show that human α-l-iduronidase (hIDUA), of which a dysfunction causes accumulation of dermatan/heparan sulfate leading to mucopolysaccharidosis type I, uses its own N-glycan as a substrate binding and catalytic module. Structural analysis revealed that the mannose residue of the N-glycan attached to N372 constituted a part of the substrate-binding pocket and interacted directly with a substrate. A deglycosylation study showed that enzyme activity was highly correlated with the N-glycan attached to N372. The kinetics of native and deglycosylated hIDUA suggested that the N-glycan is also involved in catalytic processes. Our study demonstrates a previously unrecognized function of N-glycans.

Entities:  

Keywords:  N-linked glycan; X-ray crystallography; glycoside hydrolase family 39

Mesh:

Substances:

Year:  2013        PMID: 23959878      PMCID: PMC3767532          DOI: 10.1073/pnas.1306939110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  ESPript/ENDscript: Extracting and rendering sequence and 3D information from atomic structures of proteins.

Authors:  Patrice Gouet; Xavier Robert; Emmanuel Courcelle
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

Review 2.  Assembly of asparagine-linked oligosaccharides.

Authors:  R Kornfeld; S Kornfeld
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

3.  A fluorometric assay using 4-methylumbelliferyl alpha-L-iduronide for the estimation of alpha-L-iduronidase activity and the detection of Hurler and Scheie syndromes.

Authors:  J J Hopwood; V Muller; A Smithson; N Baggett
Journal:  Clin Chim Acta       Date:  1979-03-01       Impact factor: 3.786

4.  Enzyme-replacement therapy in mucopolysaccharidosis I.

Authors:  E D Kakkis; J Muenzer; G E Tiller; L Waber; J Belmont; M Passage; B Izykowski; J Phillips; R Doroshow; I Walot; R Hoft; E F Neufeld
Journal:  N Engl J Med       Date:  2001-01-18       Impact factor: 91.245

5.  Human alpha-L-iduronidase. 1. Purification, monoclonal antibody production, native and subunit molecular mass.

Authors:  P R Clements; D A Brooks; G T Saccone; J J Hopwood
Journal:  Eur J Biochem       Date:  1985-10-01

6.  Family 39 alpha-l-iduronidases and beta-D-xylosidases react through similar glycosyl-enzyme intermediates: identification of the human iduronidase nucleophile.

Authors:  Catharine E Nieman; Alexander W Wong; Shouming He; Lorne Clarke; John J Hopwood; Stephen G Withers
Journal:  Biochemistry       Date:  2003-07-08       Impact factor: 3.162

7.  Crystal structure of beta-D-xylosidase from Thermoanaerobacterium saccharolyticum, a family 39 glycoside hydrolase.

Authors:  Jin Kuk Yang; Hye Jin Yoon; Hyung Jun Ahn; Byung Il Lee; Jean-Denis Pedelacq; Elaine C Liong; Joel Berendzen; Maris Laivenieks; Claire Vieille; Gregory J Zeikus; David J Vocadlo; Stephen G Withers; Se Won Suh
Journal:  J Mol Biol       Date:  2004-01-02       Impact factor: 5.469

8.  The structure of bovine lysosomal alpha-mannosidase suggests a novel mechanism for low-pH activation.

Authors:  Pirkko Heikinheimo; Ronny Helland; Hanna-Kirsti Schrøder Leiros; Ingar Leiros; Solveig Karlsen; Gry Evjen; Raimond Ravelli; Guy Schoehn; Rob Ruigrok; Ole Kristian Tollersrud; Seán McSweeney; Edward Hough
Journal:  J Mol Biol       Date:  2003-03-28       Impact factor: 5.469

9.  Characterization of α-l-Iduronidase (Aldurazyme®) and its complexes.

Authors:  Gangsoo Jung; Martin Pabst; Laura Neumann; Angelika Berger; Gert Lubec
Journal:  J Proteomics       Date:  2012-09-28       Impact factor: 3.855

10.  Automated main-chain model building by template matching and iterative fragment extension.

Authors:  Thomas C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-12-19
View more
  11 in total

1.  Quantitative Proteomics of the Mitotic Chromosome Scaffold Reveals the Association of BAZ1B with Chromosomal Axes.

Authors:  Shinya Ohta; Takako Taniguchi; Nobuko Sato; Mayako Hamada; Hisaaki Taniguchi; Juri Rappsilber
Journal:  Mol Cell Proteomics       Date:  2018-09-28       Impact factor: 5.911

Review 2.  X-Ray Crystallography in Structure-Function Characterization of Therapeutic Enzymes.

Authors:  Anastassios C Papageorgiou
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

3.  Insights into mucopolysaccharidosis I from the structure and action of α-L-iduronidase.

Authors:  Haiying Bie; Jiang Yin; Xu He; Allison R Kermode; Ethan D Goddard-Borger; Stephen G Withers; Michael N G James
Journal:  Nat Chem Biol       Date:  2013-09-11       Impact factor: 15.040

4.  GlycoMinestruct: a new bioinformatics tool for highly accurate mapping of the human N-linked and O-linked glycoproteomes by incorporating structural features.

Authors:  Fuyi Li; Chen Li; Jerico Revote; Yang Zhang; Geoffrey I Webb; Jian Li; Jiangning Song; Trevor Lithgow
Journal:  Sci Rep       Date:  2016-10-06       Impact factor: 4.379

5.  Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry.

Authors:  Lorne A Clarke; Roberto Giugliani; Nathalie Guffon; Simon A Jones; Hillary A Keenan; Maria V Munoz-Rojas; Torayuki Okuyama; David Viskochil; Chester B Whitley; Frits A Wijburg; Joseph Muenzer
Journal:  Clin Genet       Date:  2019-07-02       Impact factor: 4.438

6.  N-glycan structures and downstream mannose-phosphorylation of plant recombinant human alpha-L-iduronidase: toward development of enzyme replacement therapy for mucopolysaccharidosis I.

Authors:  Owen M Pierce; Grant R McNair; Xu He; Hiroyuki Kajiura; Kazuhito Fujiyama; Allison R Kermode
Journal:  Plant Mol Biol       Date:  2017-11-08       Impact factor: 4.076

Review 7.  Dissecting conformational contributions to glycosidase catalysis and inhibition.

Authors:  Gaetano Speciale; Andrew J Thompson; Gideon J Davies; Spencer J Williams
Journal:  Curr Opin Struct Biol       Date:  2014-07-10       Impact factor: 6.809

8.  Chromatin remodeller SMARCA4 recruits topoisomerase 1 and suppresses transcription-associated genomic instability.

Authors:  Afzal Husain; Nasim A Begum; Takako Taniguchi; Hisaaki Taniguchi; Maki Kobayashi; Tasuku Honjo
Journal:  Nat Commun       Date:  2016-02-04       Impact factor: 14.919

9.  Phenotype prediction for mucopolysaccharidosis type I by in silico analysis.

Authors:  Li Ou; Michael J Przybilla; Chester B Whitley
Journal:  Orphanet J Rare Dis       Date:  2017-07-04       Impact factor: 4.123

10.  Identification of a novel compound heterozygous IDUA mutation underlies Mucopolysaccharidoses type I in a Chinese pedigree.

Authors:  Yong-An Zhou; Ping Li; Yanping Zhang; Qiuhong Xiong; Chao Li; Zhonghua Zhao; Yuxian Wang; Han Xiao
Journal:  Mol Genet Genomic Med       Date:  2019-11-23       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.